课题基金 / 基金详情

Kinome Profiling of Triple Negative Breast Cancer Cells to Reveal Predictors of Response to Targeted Therapy

Kinome Profiling of Triple Negative Breast Cancer Cells to Reveal Predictors of Response to Targeted Therapy
三阴性乳腺癌细胞的激酶组分析可揭示靶向治疗反应的预测因子
批准号：
367203
负责人：
Lefebvre Cory
金额：
$1.27万
依托单位：
University of Western Ontario
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-12-01 至 2017-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=367203&lang=en
关键词：
Epidermal Growth Factor Receptor (Egfr) Kinomics Met Osteopontin (Opn) Triple Negative Breast Cancer Tyrosine Kinase Inhibitor

项目摘要

项目成果

Lefebvre Cory的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
When it comes to treating breast cancer, doctors are able to use specific drugs that target and treat a majority of breast cancers. This is not the case for TNBC (Triple Negative Breast Cancer) which can only be fought with chemotherapy and is often accom
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kinome Profiling of Triple Negative Breast Cancer Cells to Reveal Predictors of Response to Targeted Therapy
  • 批准号：
    376490
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $10.93万
  • 财政年份：
    2017
  • 负责人：
    Lefebvre Cory
  • 依托单位：
    University of Western Ontario
海外基金